To identify novel functions for DNA-PKcs activity in human cells, we utilized a rAAV-mediated gene targeting strategy to introduce a point mutation in the DNA-PKcs gene (PRKDC) that inactivates the kinase domain of DNA-PKcs in the human colon carcinoma cell line HCT116 (Figure 1A). Here, PRKDC is linked to colon carcinoma.